Lilly’s New Obesity Awareness Campaign Seeks to Shift Obesity Discourse from Blame to Science and Empathy

▴ Lilly's obesity awareness campaign featuring Varalaxmi Sarathkumar and Nicholai Sachdev
Campaign blends lived experiences with science led perspectives to challenge obesity stigma and emphasise the importance of guidance from doctors.

New Delhi, 26th February 2026: Eli Lilly and Company (India) today announced the next phase of its integrated obesity awareness initiative with a new campaign aimed at reshaping how obesity is perceived and discussed in India. The campaign, led by prominent Indian personalities, blends real-life experiences with science-led perspectives to encourage a shift in conversation from judgment and appearance towards science and empathy, reinforcing the importance of consulting a doctor as part of a comprehensive obesity care pathway. As part of the campaign, three films have been developed: the first featuring Boman Irani and Kayoze Irani; the second with Ratna Pathak Shah and Supriya Pathak; and the third featuring Varalaxmi Sarathkumar.

Obesity in India is often reduced to a question of willpower and lifestyle alone. This campaign challenges that perception by underscoring a science-based reality; as recognized by the World Health Organization (WHO), obesity is a chronic, complex disease influenced by biological, genetic, environmental, and metabolic factors. Drawing on relatable family and social contexts, the campaign reflects the experiences of individuals who frequently face judgment and self-blame, reframing these moments with empathy and scientific understanding. Within the campaign films these prominent personalities highlight the important supportive role friends and family can have in showing empathy, encouragement, and understanding, that can make visiting a doctor feel empowering rather than shameful. At the same time, the campaign affirms obesity as a medical condition, placing doctors at the centre of diagnosis and evidence-based care to encourage informed decision making and foster a more compassionate public narrative.

“Obesity has long been misunderstood in India, frequently framed as a matter of personal choice rather than acknowledged as a complex medical condition,” said Gaurav Mehta, Senior Director, Marketing and Strategic Capabilities, Eli Lilly and Company (India). “Through this next phase of our campaign, we aim to reframe the conversation by combining scientific insight with relatable, real-life narratives that reflect the lived experience of people living with obesity. Our focus is to move the dialogue from blame to understanding, reduce stigma, and empower individuals to seek appropriate, evidence-based care in consultation with qualified doctors who play a central role across the treatment journey.” 

Links to campaign films:

Obesity affects nearly 100 million individuals in India. With an adult obesity prevalence of approximately 6.5 percent in 2023, it is time to shift focus from blame and establish a new paradigm for comprehensive care along with lifestyle modification that people living with obesity deserve.1

To learn more about obesity, visit Obesity Disease & Weight Loss Health Education | Lilly India

The campaign is intended for disease awareness and education purposes only and does not promote any specific product, treatment, or therapy. Individuals are encouraged to consult qualified healthcare professionals for medical advice.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026
Dhiya Fertility and Maternity Center Performs Tamil Nadu’s First Robot-Assisted Fertility Procedure; 37-Year-Old Woman Delivers Healthy Baby GirlOctober 01, 2026
Habuild’s “Are You Still Awake?” Campaign Encourages India to Switch Off, Sleep on Time and Not Take Everything to Heart October 01, 2026